Income Tax Expense (Benefit) of Coya Therapeutics, Inc. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Coya Therapeutics, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • Coya Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $0.
  • Coya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $720,287, a 200% decline from 2023.
  • Coya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $723,852.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Coya Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 $0 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q2 2024 $0 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2

Coya Therapeutics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $720,287 -$1,444,139 -200% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 $723,852 +$723,852 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $0 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.